CA
CalciMedica, Inc.
CALC · NASDAQ
$1.86 -4.12% (-$0.08)
1M -30.94%
Market Cap $5.86M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$2.12
14.0% upside
Current Price
$1.86
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CALC is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 1.06x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 122.56%
Asset turnover 0.00x
ROA 108.91%
Debt
69 /100
Low Debt/Equity 0.00x
Int. coverage -15.40x
Current ratio 5.58x
Stability
27 /100
Unstable Beta 1.12x
Profitable years 0
EPS volatility 79.56%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CALC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
A. Rachel Leheny
Employees
15
Headquarters
La Jolla
Upcoming events
11 NOV
Earnings
Upcoming earnings report